VivoSim Labs, Inc.
NASDAQ: VIVS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Keith Murphy
- Employees
- 14
- Headquarters
- San Diego, United States
- IPO year
- 2012
- Market cap
- $2.8M
- Website
- https://vivosim.ai
Loading VIVS…
Loading profile data…Frequently asked questions about VIVS
What does VivoSim Labs, Inc. (VIVS) do?
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investig...
Where does VIVS trade?
VivoSim Labs, Inc. (VIVS) trades on the NASDAQ.
What sector is VIVS in?
VivoSim Labs, Inc. (VIVS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of VivoSim Labs, Inc.?
Keith Murphy is the chief executive officer of VivoSim Labs, Inc. (VIVS).
Where is VivoSim Labs, Inc. headquartered?
VivoSim Labs, Inc. is headquartered in United States.
Does VIVS pay a dividend?
VivoSim Labs, Inc. (VIVS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIVS go public?
VivoSim Labs, Inc. (VIVS) completed its initial public offering in 2012.